Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 12 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1494 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Sanofi has entered into a global research collaboration and licensing option with Rib-X Pharmaceuticals to develop and commercialise novel classes of antibiotics resulting from Rib-X’s RX-04 programme for the treatment of drug-resistant pathogens...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS